1 E. 7. Study Design and Statistical Issues POLICY: Every cancer genome project should state a clear rationale for its choice of sample size, in terms of the desired sensitivity to detect cancer relevant changes. The t

Source URL: icgc.org

• Medicine
• Clinical medicine
• Biology
• Anatomical pathology
• Evolutionary biology
• Genetics
• Oncology
• Molecular evolution
• Mutation
• Cancer
• Neoplasm
• Carcinoma

Microsoft Word - TOP e-spray_consolidated.docx

Source URL: www.switt.ch

• Medicine
• Biology
• Clinical medicine
• Oncology
• Applied genetics
• Medical genetics
• Medical research
• Molecular biology
• Chemotherapy
• Gene therapy
• Targeted drug delivery
• Drug delivery

Mounting evidences suggest that molecular characterization of tumors can aid treatment decisions in clinical care with a significant impact on treatment outcome. Traditionally, these analyses are performed o

Source URL: www.cancertm.com

• Medicine
• Clinical medicine
• Oncology
• Cell biology
• Biopsy
• Pathology
• Medical signs
• Exosome
• Cell-free tumour DNA
• Biomarker
• Microvesicles
• Metastasis

Excellence in Oncology ICON Laboratories’ extensive testing capabilities, combined with our clinical research experience and scientific expertise, ensure we can serve as a trusted partner in your global oncology resear

Source URL: www.aptivsolutions.com

• Laboratory techniques
• Molecular biology
• Pathology
• Biotechnology
• Medical signs
• Assay
• Multiplex
• Anatomical pathology
• Biomarker
• Reverse transcription polymerase chain reaction
• Fluorescence in situ hybridization
• Biorepository

12th International Workshop IMMUNOTHERAPY 2016: “Mapping the road for a long lasting immune-mediated control of cancer”

Source URL: www.immunotherapy.cim.co.cu

• Immunology
• Oncology
• Cancer treatments
• Cancer immunotherapy
• Immunotherapy
• Tumor microenvironment
• Adoptive cell transfer
• Cancer vaccine
• Cancer immunology
• Immune system
• Center of Molecular Immunology
• Cancer

Roland H. Stauber University Hospital of Mainz, Molecular and Cellular Oncology / ChemBioMed, Mainz (Germany) Roland H. Stauber (PhD in Biology) is Professor and Director of the Institute Molecular and Cellular Oncology,

Source URL: www.bionanomed.at

The mass spectrometry (MS) laboratory is a Core Service at Barts Cancer Institute and is currently managed by the Centre for Haemato-Oncology. MS has a variety of applications in cell and molecular biology and cancer res

Source URL: www.bci.qmul.ac.uk

• Genomics
• Bioinformatics
• Mass spectrometry
• Proteomics
• Systems biology
• Metabolomics
• Omics
• Quantitative proteomics
• Phosphorylation
• Degradomics
• Draft:Degradomics

02 02 Immunology and Oncology Research in the Department of Immunology and Oncology focusses on the molecular and cellular bases of immune system function and

Source URL: www.cnb.csic.es

• Immunology
• T helper cell
• T cell
• B cell
• Dendritic cell
• NF-B
• Antigen-presenting cell
• Immune system
• Cancer immunotherapy
• Autoimmunity
• Tumor microenvironment
• Immunotherapy

1 Scientific Program BIOCHEMISTRY/MOLECULAR ONCOLOGY Chair Persons: J. Lennartsson, A.M. Zubiaga, M.R. Sanderson

Source URL: www.spandidos-publications.com

DNA damage and DNA repair Susan P. Lees-Miller, PhD, Professor, Departments of Biochemistry & Molecular Biology and Oncology, Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada

Source URL: www.biomed.med.kyushu-u.ac.jp